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Cancer is the second most common killer in the world today, after cardiovascular disease.3 According to the World Health Organization 
(WHO),4 13% of all deaths worldwide are currently 
caused by cancer. Cancer is and will become an increass
ingly important factor in the global burden of disease in 
the decades to come. The estimated number of new cass
es each year is expected to rise from 11 million in 2002 
to 16 million by 2020.3s6 Approximately 60% (about 5.5 
million) of all these new cases are expected to occur in 
the less developed parts of the world. 
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cancer is increasingly recognized as a major health concern in the eastern mediterranean 
(em) region. the emergence of cancer and other non-communicable diseases (ncds) in most 
em region countries is related to increases in life expectancy, an increasing proportion of 
elderly people, and the successful control of most childhood communicable diseases, along 
with rapid strides in socioeconomic development. in the next 15 years, cancer incidence in 
the em is expected to increase by 100% to 180%, according to World health organization 
(Who) projection modelling, the largest increase foreseen among developing countries. 
even though 30% of cancers can be prevented and controlled using available knowledge, 
death rates will increase by 17% by 2015 because of the challenges and barriers to imple-
menting national strategic action plans. other problems facing countries in the region are the 
lack of national cancer surveillance and little harmonization in monitoring and surveillance 
methodologies. data on cancer mortality in the 21 countries is limited or lacking, with only 7 
countries having national population-based registries. there is no linking of cancer mortality 
data to ncd prevention and control. a model of integrated care for ncd prevention pro-
grams in general and cancer in particular is lacking, and finally, there is inadequate national 
capacity-building and a lack of program sustainability. the Who regional committee for the 
em has adopted a resolution recognizing the considerable magnitude of cancer as a major 
cause of morbidity, human suffering, and mortality in the region. in the last 15 years, the 
Who cancer control programme has fostered the development of national cancer control 
programs as a primary intervention strategy for a comprehensive and cost-effective approach 
at the country level. 
In the Eastern Mediterranean (EM) region, cancer is 
the fourth most common killer and increasingly recogs
nized as a major heath problem (Figure 1, Table 1).3s14 
The principal factors contributing to the projected ins
crease are the increasing proportion of elderly people 
and the overall decrease in deaths from communicable 
diseases. In addition to the changes in lifestyle results
ing in more exposure to cancer promoting substances, 
the increased prevalence of tobacco use, westernization 
of social and dietary habits, decreased physical activs
ity, and exposure to other environmental risk factors, 
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all contribute to the increased toll of cancer morbidity. 
The EM region is expected to see the most increase in 
cancer incidence in the next 15 years, with an increase 
between 100% and 180% according to projection mods
elling (Figure 2).19
The importance of cancer control was recognized at 
the 43rd Session of the WHO Regional Committee for 
the EM region, which adopted a resolution recognizing 
the considerable magnitude of cancer as a major cause 
of morbidity, human suffering and mortality in the res
gion. In the last 15 years, the WHO Cancer Control 
Program has fostered the development of national cans
cer control programs as a primary intervention strategy 
for a comprehensive and costseffective approach at the 
country level.
We now know more about the potential presdisposs
ing causes of cancer to prevent at least onesthird of all 
cancers. Tobacco is the single largest preventable cans
cerspredisposing cause in the world today. It is the mas
jor contributor for lung cancer deaths, and about 30% 
of all cancer deaths in developing countries, including 
deaths from cancer of the oral cavity, larynx, oesophas
gus, stomach, and others. A comprehensive strategy ins
cluding bans on tobacco advertising and sponsorship, 
tax increases on tobacco products, and cessation pros
grams can reduce tobacco consumption in many couns
tries. The WHO Framework Convention on Tobacco 
Control, adopted in May 2003, aims to curb tobaccos
related deaths and disease. Cancer is largely prevents
able by smoking cessation, providing healthy food, and 
avoiding exposure to carcinogens. Information is also 
available that would permit the early detection and efs
fective treatment of a further onesthird of cases. Some 
of the most frequent cancer types are curable by surgery, 
and chemotherapy and/or radiotherapy, if detected at 
an early stage. There are effective strategies for the relief 
of pain and the provision of palliative and psychosocial 
supportive care to all patients and their families, even in 
low resource settings.
Burden of Cancer
Incidence and Mortality 
The burden of cancer can be described with respect 
to incidence (newly diagnosed cases), prevalence (new 
and old cases), mortality, morbidity, or survival estis
mates. In the EM region, the absolute incidence of 
cancer was more than half million cases/year (528 729 
new cases)1s4,8s10,20s29 identified through national/local 
cancer registries or estimated from other sources. The 
crude incidence of cancers in males was found to range 
from 35.1/105 population/year in Saudi Arabia to 
Figure	1.	Deaths by Cause, eastern mediterranean region,  2002.1,14b16
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Table	1.	incidence, mortality and prevalence of cancer globally and in eastern mediterranean region (in 2002 and projection in 2030).2b
4,14,19,23
World	2002 World	2030 EMR	2002 EMR	2030
population census 6,229,629,168 8,206,457,382 492,721,000 649,074,572*
absolute incidence 11,000,000 27,000,000 529,000 1,953,714**
Deaths 7,000,000 17,000,000 272,000 1,003,145
prevalence 25,000,000 75,000,000 1,017,441 3,758,142
aassuming an average annual population growth rate of 0.98% of the world population
bCrude incidence rate of cancer increased from 1.07/1000 population in 2002 to 3.01/1000 population in 2030 in em region (assuming 181% increase). assuming the same rate of 
increase, the crude death rate increased from 0.55/1000 population to 1.545/1000 population in 2030.  also the prevalence rate increased from 2.06/1000 to 5.79 /1000 population in 2030.
140/105 population/year in Lebanon with an average 
of 97.7/105 population. In females it ranged from 33.3 
to 147.7/105 population with an average of 95.83/105 
in the same two countries. The male to female ratio was 
1.02. The age standardized rate (ASR) in males ranged 
from 58.7/105 in Saudi Arabia to 179.7/105 in Lebanon. 
In females ASR ranged from 57.5/105 in Saudi Arabia 
to 184.4/105 in Qatar. In males, lung cancer was the 
foremost cancer in onesthird of EM countries and 2nd 
to 4th in eight countries (38%) (Figure 3). Bladder and 
liver cancers were also major health problems among 
males. In nearly all EM countries, breast cancer cons
stituted a public health problem. It is the first among 
women in all countries, except Somalia and Djibouti 
(Figure 4).1s4,8s10,20s29 Tables 2 and 3 list the five most 
common cancers in males and females in each of the 21 
EM countries. Cancer represents 7% of all deaths in the 
EM region. 
Cancer Registries in the Region
In the EM region, data on cancer mortality was lacking 
and limited data from registries have been published 
on cancer incidence. A thorough and extensive review 
of Medline showed diverse sources of data, variation in 
year of issue or publication, and several national/local 
registries. Nevertheless, we tried to bring together all 
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Figure	2.	expected increase in deaths from cancer over the next 15 years by economic system and in varrious regions and countries.19
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Table	2.	The 5 most common cancer sites by country in the eastern mediterranean region, males.1b4,8b10,20b29
First Second Third Fourth Fifth
afghanistan * Stomach lung esophagus Oral cavity Colorectal
Bahrain lung prostate Bladder Colorectal Stomach
Djibouti * liver esophagus prostate Kaposi sarcoma nHl
egypt Bladder liver nHl lung leukemia
iran Stomach esophagus Colorectal Skin prostate
iraq * lung Bladder larynx nHl prostate
Jordan lung Bladder Colorectal nHl prostate
Kuwait Colorectal prostate lung liver nHl
lebanon * lung Bladder larynx leukemia prostate
libyan arab Jamhiriya * Bladder lung prostate Colorectal liver
morocco * lung Bladder prostate Stomach Colorectal
Oman nHl Stomach prostate lung Colorectal
pakistan lung Oral cavity larynx Bladder prostate
Qatar Bladder liver Colorectal nHl prostate
Saudi arabia liver Colorectal nHl lung prostate
Somalia * liver esophagus prostate nHl Stomach
Sudan * Oral cavity prostate esophagus nHl liver
Syrian arab republic Bladder leukemia lung nHl Colorectal
Tunisia lung Skin Bladder prostate Colorectal
united arab emirates Colorectal lung Stomach prostate nHl
yemen * liver nHl Colorectal esophagus Stomach
rank was done according to aSr/105 and when equal, by relative frequency.* in these countries, cancer site rank according to estimated rates.  lung cancer is the first among males in 
7/21 (33.3%) em countries, and ranked 2nd to 4th in another 8 countries (38.15).  Bladder cancer is the first in 4/22 (18.18%) and ranked 2nd to 4th in 7 countries (33.3%). liver cancer also 
ranked first in 4 countries (18.18%) and 2nd to 5th   another 4 countries.   
the currently available data on the profile of cancer in 
the 21 countries of the EM region, notably from cancer 
registries where data have not been published or have 
appeared only as journal articles or in local reports1s4,8s
10,20s29 In many cases data was not there and estimates 
were derived from Globocan 2002 (IARC). After a syss
tematic review we found that cancer incidence was res
ported through national populationsbased registries in 7 
of 21 (onesthird) in EM countries and through local or 
regional cancer registries in 6 countries (28.6%).
Despite the importance of local cancer data in devels
oping and evaluating control measures against cancer, 
up to the end of 2005, eight countries had no local or 
national cancer registries and many lacked financial or 
technical resources to collect complete, accurate and 
timely data of requisite quality. Regardless of progress 
in cancer control, however, many countries of the region 
face many constraints that must be addressed to improve 
cancer control. 
Cancer Control
The control of cancer should take a public health aps
proach aimed at reducing the causes and consequences 
of cancer by translating our knowledge into practice. 
During the last two to three decades, increasing knowls
edge has accumulated about potentially preventable cans
cer predisposing factors that can be targeted to prevent 
at least onesthird of all new cancer cases. Cancer is larges
ly preventable by smoking cessation, providing healthy 
food, and avoiding exposure to carcinogens. Information 
is also available that would permit the early detection 
and effective treatment of a further onesthird of cases. 
Some of the most frequent cancer types are curable 
by surgery, chemotherapy and/or radiotherapy. The 
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Table	3.	The 5 most Common Cancer Sites by country in the eatern mediterrenean region, females.1b4,8b10,20b29
	 First Second Third Fourth Fifth
afghanistan * Breast Stomach esophagus Cervix Ovary
Bahrain Breast Thyroid Ovary lung Stomach
Djibouti * Cervix Breast liver esophagus Ovary etc.
egypt Breast nHl liver leukemia Bladder
iran Breast Ovary & uterus Stomach Colorectal esophagus
iraq * Breast Bladder lung nHl HD
Jordan Breast Colorectal Ovary lymphoma leukemia
Kuwait Breast Colorectal Cervix Thyroid nHl
lebanon * Breast Cervix uterus leukemia Brain & CnS
libyan arab Jamhiriya* Breast uterus Bladder Colorectal leukemia
morocco * Breast Cervix Colorectal nHl Ovary etc.
Oman Breast leukemia Cervix Thyroid nHl
pakistan Breast Oral cavity Cervix esophagus lymphoma
Qatar Breast uterus Thyroid nHl Cervix
Saudi arabia Breast Thyroid Colorectal nHl Skin
Somalia * Cervix Breast liver esophagus Ovary etc.
Sudan * Breast Cervix Oral cavity esophagus Ovary etc.
Syrian arab republic Breast Cervix leukemia Colorectal Thyroid
Tunisia Breast Colorectal Bladder uterus leukemia
united arab emirates Breast Thyroid Ovary Cervix Skin
yemen * Breast Cervix esophagus Oral cavity nHl
rank was done according to aSr and if equal, according to relative frequency. * in these countries, cancer site rank according to estimated rates.  
chance of cure increases substantially if cancer is des
tected early. There are effective strategies for the relief 
of pain and the provision of palliative care and psychos
social support for all patients and their families, even 
in low resource settings. Communitysoriented cancer 
primary care is a systematic process for identifying 
and addressing most cancer health problems. Cancer 
health programs can be identified and implemented 
with the resources available in most EM countries. 
Communitysoriented cancer primary care requires 
cooperation between health professionals and coms
munity members, who work in partnership aiming for 
community awareness, early detection and screening. 
The goals are:
•  Promotion and strengthening of comprehensive 
national cancer control programs; 
•  Building international networks and partnerships 
for cancer control; 
•  Promotion of organized, evidencesbased inters
ventions for early detection of cervical and breast 
cancer; 
•  Development of guidelines on disease and pros
gram management; 
•  Advocacy for a rational approach to effective 
treatments for potentially curable tumours; 
•  Support for lowscost approaches to respond to 
global needs for pain relief and palliative care. 
WHO Cancer Control Strategy
As a response to the cancer epidemic and following the 
adoption of the Resolution on Cancer Prevention and 
Control (WHA58.22)17 at the 58th World Health 
Assembly in May 2005, the DirectorsGeneral has res
cently approved the development of various activities 
for cancer prevention and control.
The aim of the WHO Cancer Control Strategy is 
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Figure	3.	Top 5 causesof deaths due to cancer in eastern mediterranean region, 2002.23
Figure	4.	Status of cancer registries in eastern mediterranean region, 2005.1b4,8b10,20b29
to strengthen and accelerate the translation of cancer 
control knowledge into public health action. The focus 
is placed on countries to ensure the reduction of cancer 
cases and the improvement of the quality of life of pas
tients and their families. Challenges and barriers for cans
cer prevention and control in the EM region include:
•  Lack of a clear and wellsdocumented public health 
policy for all NCDs, including cancer in most of 
EM countries.
•  Lack of political support to develop legislation and 
regulation to:
–  Build up and enhance the viability of cancer 
registries;
–  Control tobacco, which alone could pres
vent onesthird of cancers in many of EM 
countries and which has been ratified  by 
national populationbbased registry
regional populationbbased registry
Frequency data
no data available
number of deaths
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the Framework Convention on Tobacco 
Control but with no effective legislation;
–  Endorse WHO global strategy on diet, 
physical activity and health (DPAS).
WHO Stepwise Approaches for Cancer 
Prevention and Care
WHO outlines a stepwise2s4 framework that ministries 
of health can use to create a policy and regulatory ens
vironment in which other sectors can operate successs
fully. The guidance and recommendations provided may 
be used by national as well as subsnational level policys
makers and planners. Elements of this approach include 
the following:
•  The national governments need to a unifying frames
work for cancer prevention and control that will ens
sure that actions at all levels and by all sectors are 
mutually supportive.
•  Integrated prevention and control strategies are 
most effective, focusing on the common risk factors 
and cutting across specific diseases.
•  Comprehensive public health action requires a 
combination of interventions for the whole populas
tion and for individuals.
•  Most countries will not have the immediate res
sources to do everything that would ideally be done. 
Those activities which are most feasible given the 
existing context should be implemented first: this is 
the stepwise approach.
•  Because major determinants of the cancer burden 
lie outside the health sector, intersectoral interacs
tion is necessary at all stages of policy formulation 
and implementation.
•  Locally relevant and explicit milestones should be 
established for each step and at each level of inters
vention, with a particular focus on reducing health 
inequalities.
Strategic Directions
In the EM region, noncommunicable diseases are the 
major cause of premature adult deaths, representing a 
major health challenge. More than 30% of cancers can 
be prevented and controlled by using available knowls
edge. However, without national strategic action, deaths 
from cancer are expected to increase by 17% between 
2005 and 2015.1s4 Despite global successes, such as the 
WHO17 Framework Convention on Tobacco Control, 
the first legal instrument designed to reduce tobaccosres
lated deaths and disease around the world, cancer has 
generally been neglected in international health and des
velopment work.
There are several problems facing countries of the 
region: 
• Lack of national cancer surveillance; 
•  Lack of harmonization of monitoring and surveils
lance methodologies; 
•  No linking of cancer mortality data to noncommus
nicable disease prevention and control; lack of avails
ability of a model of integrated care for noncommus
nicable disease prevention program in general and 
cancer in particular, and
•  Inadequate national capacitysbuilding and a lack of 
program sustainability.
Six Main Strategic Directions: 
1.  Estimate population need and advocate for 
action
Many countries of the region do not have a surveillance 
system for cancer. Knowledge of cancer risk factors is 
important for predicting the burden of cancer in popus
lations and for identifying potential interventions to res
duce such burdens. The World Health Report 200211, 24 
identified eight risk factors that contribute the most to 
mortality and morbidity, that can be changed through 
primary intervention and that can be easily measured 
in populations. These are tobacco, alcohol use, physis
cal inactivity, low fruit/vegetable intake, obesity, raised 
blood pressure, raised cholesterol, and diabetes. In fact, 
the joint effects of tobacco raised blood pressure and 
raised cholesterol account for 65% of all cardiovascular 
disease and cancer in those above the age of 30 years. 
2.  Develop national policies, strategies and 
plans for cancer disease prevention and care 
and capacity-building
As 30% of cancer can be prevented and controlled using 
available knowledge, a comprehensive and integrated 
approach is required at the country level, led by the govs
ernment, and with the full participation of the whole 
community. The populationswide approach seeks to 
reduce the risks in the entire population. Cancer can be 
reduced by small reductions in the average population 
levels of several known risk factors, such as tobacco cons
sumption and unhealthy diets. Populationswide and ins
dividual approaches are complementary strategies that 
provide a continuum of interventions. Countries of the 
region need to set strategies for developing a model of 
integrated care for cancer prevention and national cas
pacitysbuilding.
3.  Promote and implement community partici-
pation in prevention and care of cancer
Integrated communitysbased intervention programs 
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for prevention and care of cancer are comprehensive 
packages in which different kinds of activities are coms
bined to produce a synergetic effect. The community 
approach in cancer prevention has a high degree of 
generalization and costseffectiveness, is able to diffuse 
information successfully, and has the potential for ins
fluencing environmental and institutional policies that 
have a bearing on the health status of the population. 
Close collaboration between those implementing the 
community approach and the national health authoris
ties is important to sustain the program and for influs
encing policy development in regard to health.
4.  Public health policy for cancer prevention 
(creating healthy social and physical environ-
ments)
There are two main approaches to fostering health 
public policies: health advocacy and community orgas
nization. Health advocacy is the process of convincing 
decision makers to take action on cancer prevention 
and healthsrelated issues. Community organiztion is 
the process of utilizing and mobilizing communities to 
share and actively participate in cancer prevention and 
health concerns.
For the costseffective approach, all efforts to facilitate 
the role of community should enable the individuals 
and communities to be actively involved to control the 
factors affecting their health. Education, public health 
policy, and environmental support are complementary 
approaches to health promotion.
WHO2s4 had set some policies that could enhance 
cancer control like:
•  Ensuring tobacco is taxed at an appropriate levs
el, and that tobacco taxes are increased at least 
enough to keep pace with increases in the cost of 
living;
•  Introducing legislation banning smoking in the 
workplace and schools;
• Introducing obligatory warning labels on tobacco;
•  Introducing legislation to reduce exposure of 
workers to carcinogens in the workplace;
•  Ensuring hepatitis B vaccination is included in exs
panded programs of immunization of children in 
countries with high HBV transmission rates.
Seventy per cent of EM countries are low resource 
countries and should focus on areas where there are 
not only great needs, but also the potential for success. 
The national strategies need to consider priority stas
tus for cancer prevention strategies and direct special 
attention to target and combat infections that may 
promote cancer development, such as schistosomiasis 
and hepatitis B. In areas of endemicity for liver cans
cer, Hepatitis B Vaccination should be integrated with 
other vaccination programs.
5. Priority actions for palliative care
WHO2s4 recommends implementing comprehensive 
palliative care programs with the purpose of improvs
ing the quality of life of the majority of patients with 
cancer and their families. Awareness among public 
health professionals that cancer pain should be props
erly controlled and ensure the availability of essential 
WHO2s4 palliative care medications list. In low res
sources settings, it is important to ensure that minis
mum standards for pain relief and palliative care are 
progressively adopted at all levels of care. Homesbased 
care is generally the best way of achieving good quality 
care and coverage in counties with strong family sups
port and poor health infrastructure.
6.  Implementing national cancer control pro-
grams
The implementing of a national cancer control pros
gram, tailored to the socioeconomic and cultural cons
text, should allow countries to efficiently and effectives
ly translate current knowledge into action. The overall 
aims of a national cancer control program are to reduce 
the incidence and mortality of cancer, as well as to ims
prove overall survival and quality of life of cancer pas
tients and their families. The goals of a national cancer 
control program may be summarized as follows:
•  To prevent future cancers;
• To diagnose cancers early;
• To provide curative therapy;
• To ensure freedom from suffering;
• To reach all members of the population.
Conclusion
A communitysoriented primary cancer care approach 
is needed and it should be an opportunity for low 
resources countries to expand division of cancer 
health care to include both primary care and populas
tion health. This will help in improving the health of 
communities. Health professionals are being asked to 
change their ways of caring for people because mans
aged care emphasizes and scrutinizes outcomes of care 
as never before.
WHO has developed, in close collaboration with 
its member states, a global strategy for the prevention 
and control of noncommunicable diseases in which 
cancer control appears as one of the four major pris
orities. The global strategy was endorsed by the 53rd 
World Health Assembly held in May 200017 and ems
phasizes the need for an integrated approach to health 
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promotion and noncommunicable disease prevention 
strategies. The need for a comprehensive vision to ads
dress the health and economic burden of cancer in the 
EM region countries and region is clear and urgent. 
Regional and national strategies are essential for coms
munity mobilization and for developing and imples
menting successful and sustainable cancer prevention 
and control policies and programs. 
Cancer control and care represent a challenging 
task, nationally and regionally. Advocacy is needed 
to raise awareness of cancer and create a climate for 
resource mobilization. Two key messages for advos
cacy are: a) noncommunicable diseases are the major 
disease burden and b) 30% of cancers are preventable 
by using available knowledge, and the solutions are efs
fective and highly costseffective. Research is needed 
to explore the effectiveness of communitysbased pros
grams for noncommunicable disease prevention and 
control in general and cancer in specific. The establishs
ment of a national cancer control program, tailored to 
the socioeconomic and cultural context, should allow 
countries to efficiently and effectively translate press
ent knowledge into action. Finally, implementation of 
the necessary measures requires the formulation of 
evidencesbased policies, the mobilization and appros
priate allocation of resources, the active participation 
of all stakeholders and a government commitment to 
legislation, education, and international collaboration 
in support of cancer control.
We acknowledge the work of John Cathey in editing the 
manuscript.
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